nach oben

Medizinische Klinik - Intensivmedizin und Notfallmedizin

Erschienen in:

17.12.2015 | Originalien

Influence of the serum levels of immunoglobulins on clinical outcomes in medical intensive-care patients

verfasst von: C. Geier, J. Schröder, A. Tamm, S. Dietz, S. Nuding, K. Holder, Ö. Khandanpour, K. Werdan, Prof. Dr. H. Ebelt, MD

Erschienen in: Medizinische Klinik - Intensivmedizin und Notfallmedizin | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Endogenous immunoglobulins (Igs) are of fundamental importance in the host defense after microbial infections. However, the therapeutic administration of intravenous IgG (IVIgG) has not yet been shown to improve clinical outcomes in patients suffering from sepsis, and in the case of IgM-containing preparations (IVIgGMA) the positive evidence is only weak. Recently published studies implicate that Ig levels on admission could have an impact on the patient’s response to IVIg treatment and on outcomes of critically ill patients.

Methods

In this noninterventional study, the serum levels of IgG, IgM, and IgA were determined in 340 medical patients on ICU admission, and clinical outcomes were prospectively recorded (ICU mortality, need for renal replacement therapy (RRT), need for mechanical ventilation, substitution of coagulation factors, and amount of red cell transfusions). Patients were prospectively grouped according to their main reason for ICU admission (sepsis, respiratory failure, cardiovascular diseases, acute renal failure, postoperative condition, state after cardiopulmonal resuscitation, gastrointestinal diseases, and others).

Results and discussion

There was no correlation between the Ig levels on admission and ICU mortality neither in the total cohort of medical ICU patients nor in any prespecified subgroup. However, in a logistic regression model that was adjusted for APACHE II score on admission, an increase in serum IgG was associated with a reduced need for mechanical ventilation in patients suffering from cardiovascular disease. On the other hand, in patients suffering from sepsis, an increased level of IgM was linked to an increased administration of coagulation factors.

Conclusion

Our data do not support the hypothesis that serum levels of immunoglobulins are linked to mortality in medical ICU patients.

Ballow M (2002) Primary immunodeficiency disorders: antibody deficiency. J Allergy Clin Immunol 109(4):581–591CrossRefPubMed

Cafiero F, Gipponi M, Bonalumi U, Piccardo A, Sguotti C, Corbetta G (1992) Prophylaxis of infection with intravenous immunoglobulins plus antibiotic for patients at risk for sepsis undergoing surgery for colorectal cancer: results of a randomized, multicenter clinical trial. Surgery 112(1):24–31PubMed

Durandy A, Kaveri SV, Kuijpers TW, Basta M, Miescher S, Ravetch JV, Rieben R (2009) Intravenous immunoglobulins—understanding properties and mechanisms. Clin Exp Immunol 158(Suppl 1):2–13CrossRefPubMedPubMedCentral

Forastiero R, Martinuzzo M, Pombo G, Puente D, Rossi A, Celebrin L et al (2005) A prospective study of antibodies to beta2-glycoprotein I and prothrombin, and risk of thrombosis. J Thromb Haemost 3(6):1231–1238CrossRefPubMed

Giamarellos-Bourboulis EJ, Raftogiannis M (2012) The immune response to severe bacterial infections: consequences for therapy. Expert Rev Anti Infect Ther 10(3):369–380CrossRefPubMed

Hentrich M, Fehnle K, Ostermann H, Kienast J, Cornely O, Salat C et al (2006) IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: a randomized, controlled, multiple-center trial. Crit Care Med 34(5):1319–1325CrossRefPubMed

Imai H, Nakamoto Y, Asakura K, Miki K, Yasuda T, Miura AB (1985) Spontaneous glomerular IgA deposition in ddY mice: an animal model of IgA nephritis. Kidney Int 27(5):756–761CrossRefPubMed

Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13(10):818–829CrossRefPubMed

Kreymann KG, Heer G de, Nierhaus A, Kluge S (2007) Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock. Crit Care Med 35(12):2677–2685CrossRefPubMed

10.

Laupland KB, Kirkpatrick AW, Delaney A (2007) Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis. Crit Care Med 35(12):2686–2692CrossRefPubMed

11.

Layward L (1993) Elevation of IgA in IgA nephropathy is localized in the serum and not saliva and is restricted to the IgA1 subclass. Nephrol Dial Transplant 8(1):25–28PubMed

12.

Levi M, Schultz M, van der Poll T (2013) Sepsis and thrombosis. Semin Thromb Hemost 39(5):559–566CrossRefPubMed

13.

Maeda A, Gohda T, Funabiki K, Horikoshi S, Shirato I, Tomino Y (2003) Significance of serum IgA levels and serum IgA/C3 ratio in diagnostic analysis of patients with IgA nephropathy. J Clin Lab Anal 17(3):73–76CrossRefPubMed

14.

Miyawaki S, Muso E, Takeuchi E, Matsushima H, Shibata Y, Sasayama S, Yoshida H (1997) Selective breeding for high serum IgA levels from noninbred ddY mice: isolation of a strain with an early onset of glomerular IgA deposition. Nephron 76(2):201–207CrossRefPubMed

15.

Nakayama K, Ohsawa I, Maeda-Ohtani A, Murakoshi M, Horikoshi S, Tomino Y (2008) Prediction of diagnosis of immunoglobulin A nephropathy prior to renal biopsy and correlation with urinary sediment findings and prognostic grading. J Clin Lab Anal 22(2):114–118CrossRefPubMed

16.

Päsler M (2012) Hypogammaglobulinemia in sepsis. Annu Update Intensive Care Emerg Med 2012:98–108

17.

Pildal J, Gotzsche PC (2004) Polyclonal immunoglobulin for treatment of bacterial sepsis: a systematic review. Clin Infect Dis 39(1):38–46CrossRefPubMed

18.

Reinhart K, Brunkhorst FM, Bone H-G, Bardutzky J, Dempfle C-E, Forst H et al (2010) Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e. V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine (Deutsche Interdisziplinare Vereinigung fur Intensiv- und Notfallmedizin (DIVI)). Ger Med Sci 8: Doc14

19.

Rochwerg B, Wludarczyk A, Szczeklik W, Alhazzani W, Sindi A, Alshamsi F et al (2013) Fluid resuscitation in severe sepsis and septic shock: systematic description of fluids used in randomized trials. Pol Arch Med Wewn 123(11):603–608PubMed

20.

Rodriguez A, Rello J, Neira J, Maskin B, Ceraso D, Vasta L, Palizas F (2005) Effects of high-dose of intravenous immunoglobulin and antibiotics on survival for severe sepsis undergoing surgery. Shock 23(4):298–304CrossRefPubMed

21.

Roos A, Rieben R, Faber-Krol MC, Daha MR (2003) IgM-enriched human introvenous immunoglobulin strongly inhibits complement-dependent porcine cell cytotoxicity mediated by human xenoreactive antibodies. Xenotransplantation 10(6):596–605CrossRefPubMed

22.

Salobir B, Sabovic M, Hojnik M, Cucnik S, Kveder T (2007) Anti-beta 2-glycoprotein I antibodies of IgM class are linked to thrombotic disorders in young women without autoimmune disease. Immunobiology 212(3):193–199CrossRefPubMed

23.

Schedel I, Dreikhausen U, Nentwig B, Hockenschnieder M, Rauthmann D, Balikcioglu S et al (1991) Treatment of gram-negative septic shock with an immunoglobulin preparation: a prospective, randomized clinical trial. Crit Care Med 19(9):1104–1113CrossRefPubMed

24.

Schwartz-Albiez R, Monteiro RC, Rodriguez M, Binder CJ, Shoenfeld Y (2009) Natural antibodies, intravenous immunoglobulin and their role in autoimmunity, cancer and inflammation. Clin Exp Immunol 158(Suppl 1):43–50CrossRefPubMedPubMedCentral

25.

Spycher M, Matozan K, Minnig K, Zehnder R, Miescher S, Hoefferer L, Rieben R (2009) In vitro comparison of the complement-scavenging capacity of different intravenous immunoglobulin preparations. Vox Sang 97(4):348–354CrossRefPubMed

26.

Taccone FS, Stordeur P, Backer D de, Creteur J, Vincent J-L (2009) Gamma-globulin levels in patients with community-acquired septic shock. Shock 32(4):379–385CrossRefPubMed

27.

Tomino Y (2012) Predictors of prognosis in IgA nephropathy. Kaohsiung J Med Sci 28(10):517–520CrossRefPubMed

28.

Turgeon AF, Hutton B, Fergusson DA, McIntyre L, Tinmouth AA, Cameron DW, Hebert PC (2007) Meta-analysis: intravenous immunoglobulin in critically ill adult patients with sepsis. Ann Intern Med 146(3):193–203CrossRefPubMed

29.

Venet F, Gebeile R, Bancel J, Guignant C, Poitevin-Later F, Malcus C et al (2011) Assessment of plasmatic immunoglobulin G, A and M levels in septic shock patients. Int Immunopharmacol 11(12):2086–2090CrossRefPubMed

30.

Walpen AJ, Laumonier T, Aebi C, Mohacsi PJ, Rieben R (2004) Immunoglobulin M-enriched intravenous immunoglobulin inhibits classical pathway complement activation, but not bactericidal activity of human serum. Xenotransplantation 11(2):141–148CrossRefPubMed

31.

Werdan K (2001) Intravenous immunoglobulin for prophylaxis and therapy of sepsis. Curr Opin Crit Care 7(5):354–361CrossRefPubMed

32.

Werdan K (2001) Pathophysiology of septic shock and multiple organ dysfunction syndrome and various therapeutic approaches with special emphasis on immunoglobulins. Ther Apher 5(2):115–122CrossRefPubMed

33.

Werdan K, Pilz G, Bujdoso O, Fraunberger P, Neeser G, Schmieder RE et al (2007) Score-based immunoglobulin G therapy of patients with sepsis: the SBITS study. Crit Care Med 35(12):2693–2701CrossRefPubMed

34.

Werdan K, Pilz G, Müller-Werdan U, Maas Enriquez M, Schmitt DV, Mohr F-W et al (2008) Immunoglobulin G treatment of postcardiac surgery patients with score identified severe systemic inflammatory response syndrome—the ESSICS study. Crit Care Med 36(3):716–723CrossRefPubMed

35.

Zanon E, Prandoni P, Vianello F, Saggiorato G, Carraro G, Bagatella P, Girolami A (1999) Anti-beta2-glycoprotein I antibodies in patients with acute venous thromboembolism: prevalence and association with recurrent thromboembolism. Thromb Res 96(4):269–274CrossRefPubMed

36.

Zeerleder S, Hack CE, Wuillemin WA (2005) Disseminated intravascular coagulation in sepsis. Chest 128(4):2864–2875CrossRefPubMed

Titel: Influence of the serum levels of immunoglobulins on clinical outcomes in medical intensive-care patients
verfasst von: C. Geier
J. Schröder
A. Tamm
S. Dietz
S. Nuding
K. Holder
Ö. Khandanpour
K. Werdan
Prof. Dr. H. Ebelt, MD
Publikationsdatum: 17.12.2015
Verlag: Springer Medizin
Erschienen in: Medizinische Klinik - Intensivmedizin und Notfallmedizin / Ausgabe 1/2017
Print ISSN: 2193-6218
Elektronische ISSN: 2193-6226
DOI: https://doi.org/10.1007/s00063-015-0121-0

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren

Springer Medizin

Influence of the serum levels of immunoglobulins on clinical outcomes in medical intensive-care patients